FJ Pharma

Bilzen-Hoeselt ·KBO/BCE: BE 0771.593.428

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	02-03-2026	151 d early	2026-00049216
31-12-2024	31-07-2025	16-05-2025	76 d early	2025-00096069
31-12-2023	31-07-2024	02-06-2024	59 d early	2024-00104656
31-12-2022	31-07-2023	31-07-2023	on the day	2023-00293610

Metric	This company	Sector median	Position in the sector
Solvency	73.8%	55.5%	better than 68% of 4723 sector peers
Net result	€8k	€38k	better than 23% of 4722 sector peers
Equity	€49k	€64k	better than 43% of 4723 sector peers
Gross operating margin	€14k	€61k	better than 18% of 4715 sector peers
Total assets	€66k	€146k	better than 22% of 4723 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€66k
Fixed assets	21/28	€6k
Tangible fixed assets	22/27	€6k
Current assets	29/58	€60k
Amounts receivable within one year	40/41	€22k
Cash & bank	54/58	€38k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€66k
Equity	10/15	€49k
Contributions / capital	10/11	€3k
Reserves	13	€46k
Accumulated profits (losses)	14	€0
Amounts payable	17/49	€17k
Amounts payable within one year	42/48	€17k
Trade debts payable within one year	44	€2k
Income statement
Gross operating margin	9900	€14k
Operating result	9901	€11k
Financial income	75	€0
Financial charges	65	€150
Result before taxes	9903	€11k
Income taxes	67/77	€3k
Net result for the period	9904	€8k
Result to be appropriated	9905	€8k

Summary